HEPATO-GASTROENTEROLOGY, vol.55, no.85, pp.1158-1163, 2008 (SCI-Expanded)
Background/Aims: 5-Fluorouracil-based chemoradiotherapy is the most widely used treatment modality in the adjuvant treatment of rectal cancer. Capecitabine represents a valuable alternative to 5-Fluorouracil in this situation.